Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations.
- Published In:
- Xenobiotica; the fate of foreign compounds in biological systems, 52(8), 828-839 (2022)
- Authors:
- Esposito, Simone(3), Orsatti, Laura, Pucci, Vincenzo
- Database ID:
- RPEP-06112
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06112APA
Esposito, Simone; Orsatti, Laura; Pucci, Vincenzo. (2022). Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations.. Xenobiotica; the fate of foreign compounds in biological systems, 52(8), 828-839. https://doi.org/10.1080/00498254.2022.2119180
MLA
Esposito, Simone, et al. "Subcutaneous catabolism of peptide therapeutics: bioanalytical approaches and ADME considerations.." Xenobiotica; the fate of foreign compounds in biological systems, 2022. https://doi.org/10.1080/00498254.2022.2119180
RethinkPeptides
RethinkPeptides Research Database. "Subcutaneous catabolism of peptide therapeutics: bioanalytic..." RPEP-06112. Retrieved from https://rethinkpeptides.com/research/esposito-2022-subcutaneous-catabolism-of-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.